These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Abe S, Ota Y, Doi Y, Nomoto A, Nomura T, Chumakov KM, Hashizume S. Virology; 1995 Jun 20; 210(1):160-6. PubMed ID: 7793068 [Abstract] [Full Text] [Related]
5. Microevolution of type 3 Sabin strain of poliovirus in cell cultures and its implications for oral poliovirus vaccine quality control. Rezapkin GV, Norwood LP, Taffs RE, Dragunsky EM, Levenbook IS, Chumakov KM. Virology; 1995 Aug 20; 211(2):377-84. PubMed ID: 7645242 [Abstract] [Full Text] [Related]
6. Engineering attenuated virus vaccines by controlling replication fidelity. Vignuzzi M, Wendt E, Andino R. Nat Med; 2008 Feb 20; 14(2):154-61. PubMed ID: 18246077 [Abstract] [Full Text] [Related]
7. Infectious cDNA clone of attenuated Langat tick-borne flavivirus (strain E5) and a 3' deletion mutant constructed from it exhibit decreased neuroinvasiveness in immunodeficient mice. Pletnev AG. Virology; 2001 Apr 10; 282(2):288-300. PubMed ID: 11289811 [Abstract] [Full Text] [Related]
8. Transgenic PVR Tg-1 mice for testing of poliovirus type 3 neurovirulence: comparison with monkey test. Dragunsky E, Gardner D, Taffs R, Levenbook I. Biologicals; 1993 Sep 10; 21(3):233-7. PubMed ID: 8117436 [Abstract] [Full Text] [Related]
9. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants. Calvez V, Pelletier I, Couderc T, Pavio-Guédo N, Blondel B, Colbère-Garapin F. Virology; 1995 Oct 01; 212(2):309-22. PubMed ID: 7571400 [Abstract] [Full Text] [Related]
10. Assessment of the viral RNA sequence heterogeneity for control of OPV neurovirulence. Chumakov K, Norwood L, Parker M, Dragunsky E, Taffs R, Ran Y, Ridge J, Levenbook I. Dev Biol Stand; 1993 Oct 01; 78():79-89; discussion 88-9. PubMed ID: 8388834 [Abstract] [Full Text] [Related]
14. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Abe S, Ota Y, Koike S, Kurata T, Horie H, Nomura T, Hashizume S, Nomoto A. Virology; 1995 Feb 01; 206(2):1075-83. PubMed ID: 7856082 [Abstract] [Full Text] [Related]
15. Live-attenuated strains of improved genetic stability. Macadam AJ, Ferguson G, Stone DM, Meredith J, Almond JW, Minor PD. Dev Biol (Basel); 2001 Feb 01; 105():179-87. PubMed ID: 11763326 [Abstract] [Full Text] [Related]
16. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice. Blaney JE, Johnson DH, Firestone CY, Hanson CT, Murphy BR, Whitehead SS. J Virol; 2001 Oct 01; 75(20):9731-40. PubMed ID: 11559806 [Abstract] [Full Text] [Related]
18. Neurovirulence. Wood D. Dev Biol Stand; 1999 Oct 01; 101():127-9. PubMed ID: 10566785 [Abstract] [Full Text] [Related]
19. Towards development of an in vitro translation test for poliovirus neurovirulence. Svitkin YV, Alpatova GA, Lipskaya GA, Maslova SV, Agol VI, Kew O, Meerovitch K, Sonenberg N. Dev Biol Stand; 1993 Oct 01; 78():27-32. PubMed ID: 8388829 [Abstract] [Full Text] [Related]